• Huda M Al-Mutairi, Oluwaseun Egunsola, Afaf Almutairi, Salha M Al-Dossary, Rana S Alshammasi, Dalal S Al-Dossari, and Sheraz Ali.
• From the Pharmaceutical Care Services (Al-Mutairi, Alshammasi, Al-Dossary S, Al-Dossari D), from the Internal Medicine Department (Almutairi), King Saud Medical City, Ministry of Health, Riyadh, Kingdom of Saudi Arabia; from the Department of Community Health Sciences (Egunsola), University of Calgary, Canada; and from the School of Pharmacy and Pharmacology (Ali), University of Tasmania, Sandy Bay, Australia.
• Saudi Med J. 2021 Dec 1; 42 (12): 1333-1340.

ObjectivesTo assess the clinical and epidemiological characteristics of hospitalized cancer patients with skin and soft-tissue infections (SSTIs).MethodsAn observational retrospective study was conducted between March 2016 and December 2020 at the Oncology Department of King Saudi Medical City, Riyadh, Saudi Arabia. Patients with complicated and uncomplicated SSTIs were included.ResultsA total of 204 cancer patients with SSTIs were evaluated. The incidence of SSTIs was 1.67% (204/12,203). Breast cancer (39%) was the most common solid tumor in all patients with SSTIs. Exit site infection (n=84, 41.2%) was the most common SSTI in cancer patients, followed by wound infection (n=72, 35.3%), and cellulitis (n=44, 21.5%). The majority of patients received appropriate antimicrobial therapy (n=150, 73.5%).ConclusionThis study has shown a modest incidence of SSTIs in hospitalized cancer patients, with many of the patients received appropriate antimicrobial therapy.Copyright: © Saudi Medical Journal.

16 keywords...

hide…